0001093557-23-000236.txt : 20231127 0001093557-23-000236.hdr.sgml : 20231127 20231127193417 ACCESSION NUMBER: 0001093557-23-000236 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231109 FILED AS OF DATE: 20231127 DATE AS OF CHANGE: 20231127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Naganathan Girish CENTRAL INDEX KEY: 0001949138 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 231441585 MAIL ADDRESS: STREET 1: C/O DEXCOM, INC. STREET 2: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-11-09 0 0001093557 DEXCOM INC DXCM 0001949138 Naganathan Girish 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 EVP Chief Technology Officer 0 Common Stock 2023-11-09 4 S 0 2725 93.27 D 47725 D Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Included in this number are 42,363 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 23,587 of which were granted on November 8, 2022 and shall vest through November 8, 2026. By: Jereme Sylvain For: Girish Naganathan 2023-11-27